Cargando…
Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
BACKGROUND: High override rates for drug-drug interaction (DDI) alerts in electronic health records (EHRs) result in the potentially dangerous consequence of providers ignoring clinically significant alerts. Lack of uniformity of criteria for determining the severity or validity of these interaction...
Autores principales: | Phansalkar, Shobha, Desai, Amrita, Choksi, Anish, Yoshida, Eileen, Doole, John, Czochanski, Melissa, Tucker, Alisha D, Middleton, Blackford, Bell, Douglas, Bates, David W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706355/ https://www.ncbi.nlm.nih.gov/pubmed/23763856 http://dx.doi.org/10.1186/1472-6947-13-65 |
Ejemplares similares
-
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables
por: Tyson, Rachel J., et al.
Publicado: (2020) -
Lost in Translation: No Effect of a High‐Profile Publication on the Concomitant Use of Interacting Drugs
por: Acton, Emily K., et al.
Publicado: (2017) -
Variation in high-priority drug-drug interaction alerts across institutions and electronic health records
por: McEvoy, Dustin S, et al.
Publicado: (2017) -
Priority setting of health interventions: the need for multi-criteria decision analysis
por: Baltussen, Rob, et al.
Publicado: (2006) -
Toward Scalable Clinical Decision Support
por: Aziz, Boxwala, et al.
Publicado: (2010)